Testing effectiveness (Phase 2)Study completedNCT00266253
What this trial is testing
GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 220